ScholarIQanswers from OpenAlex

Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure

PaperCitations, authors & open-access status

Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure have?

ScholarIQcitation count

Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure has 14 citations in the OpenAlex counts ScholarIQ stores.

When was Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure published?

ScholarIQyear

Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure has 2022 year in the ScholarIQ index.

What is the open-access status of Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure?

ScholarIQoa status

Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure has gold oa status in the ScholarIQ index.

What is the DOI of Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure?

ScholarIQdoi

The DOI for Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure is on the source record.

What is the PMID of Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure?

ScholarIQpmid

The PMID for Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure is on the source record.

What is the OpenAlex record for Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure?

ScholarIQopenalex

The OpenAlex for Impact of Financial Considerations on Willingness to Take Sacubitril/Valsartan for Heart Failure is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial